CIK 0001815442 · Large accelerated filer
Kymera Therapeutics, Inc.
Sign in to watch- Ticker
- KYMR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812992166
- Phone
- 857-285-5314
- Business address
- 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
- Former names
- Kymera Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,158,214
- in 2 filings, $3.4M under 10b5-1 plans
Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-04 | Adams Brian Chief Legal Officer | Sale | −1,209 | $115.55 | $140K | 55,416 |
| 2026-09-04 | Adams Brian Chief Legal Officer | Sale | −3,025 | $116.81 | $353K | 52,391 |
| 2026-09-04 | Adams Brian Chief Legal Officer | Sale | −2,137 | $117.57 | $251K | 50,254 |
| 2026-03-02 | Adams Brian Chief Legal Officer | Grant or award | +4,125 | 56,625 | ||
| 2026-03-02 | Adams Brian Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +8,250 | 8,250 | ||
| 2025-09-03 | Adams Brian Chief Legal Officer | Grant or award | +52,500 | 52,500 | ||
| 2025-09-03 | Adams Brian Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +105,000 | 105,000 |
Page 1 of 1 · 7 trades